Although our findings prove that the higher expression of NOTCH1 is statistically significantly associated with the higher stage of cancer, there is a possibility of other mechanisms (e.g., simultaneous activation of other oncogenic signaling pathways, e.g., PI3K/AKT or EGFR) to play a role in immune evasion and tumor progression. The gene discussed is EGFR; the disease is cancer.